STENTYS Self-Apposing® sirolimus-eluting stent in ST-segment elevation myocardial infarction : results from the randomised APPOSITION IV trial

Publié dans EuroIntervention 2016 Feb;11(11):e1267-74 Auteurs : van Geuns RJ, Yetgin T, La Manna A, Tamburino C, Souteyrand G, Motreff P, Koch KT, Vrolix M, IJsselmuiden A, Amoroso G, Berland J, Montalescot G, Teiger E, Christiansen EH, Spaargaren R, Wijns W. Article disponible en consultant le site Abstract Background and aim : We sought to…

Potent P2Y12 Inhibitors in Low Risk Patients : Is There a Medical Need ?

Publié dans Journal of the American College of Cardiology 2016 Feb 16;67(6):614-617 Auteurs : Silvain J, Kerneis M, Montalescot G. Article disponible en consultant le site Editorial comment The oral P2Y12 inhibitors prasugrel and ticagrelor have demonstrated biological and clinical superiority over clopidogrel, with a faster onset of action and greater potency, which translate into…

Moving Toward Eradication of Stent Thrombosis

Publié dans Journal of the American College of Cardiology 2016 Feb 23;67(7):763-5 Auteurs : Barthélémy O, Montalescot G. Article disponible en consultant le site Editorial comment Improved clinical outcomes have supported the use of drug-eluting stents (DES) in preference to bare-metal stents. However, the possibility of late occlusive stent thrombosis (ST), a long-term iatrogenic complication,…

Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel : The Randomized Cross-Over AMPHORE Study

Publié dans American Journal of Cardiovascular Drugs 2016 Feb;16(1):43-53 Auteurs : Collet JP, Funck-Brentano C, Prats J, Salem JE, Hulot JS, Guilloux E, Hu MY, He K, Silvain J, Gallois V, Brugier D, Anzaha G, Galier S, Nicolas N, Montalescot G. Article disponible en consultant le site Abstract Background and aim : The extent of…